Literature DB >> 10662985

[Dilated coronary sinus. A preoperative transesophageal echocardiographic diagnosis].

W Paul1, B Beisel, A Krug, A Vagt, A Timpe, R Brase, K H Leitz, F Böhmert, W Kuckelt.   

Abstract

A 36-year old woman was presented to our hospital with congenital ventricular septal defect and one-vessel coronary artery disease (75% proximal left main coronary artery) for CABG and repair of the VSD. After induction, a transesophageal echocardiographic (TEE) baseline examination was performed, showing a severely dilated coronary sinus (CS) measuring approximately 3 cm (abnormal >1 cm). We suggested a persistent left superior vena cava (PLSVC) draining into the CS. PLSVC is a common venous congenital anomaly, with a reported incidence of 0.5% in general population and in 3-5 % of patients with congenital heart defect. Injection of echo-contrast solution in a left arm vein, visualizing microbubbles passing through the PLSVC into the CS confirmed our suspicion. The diagnosis of a PLSVC and dilated CS is a contraindication for retrograde cardioplegia because of the loss of cardioplegia into the PLSVC resulting in a inadequate myocardial protection. It may be difficult to pass a pulmonary artery catheter (PAC) through a left internal or left subclavian vein and it may be associated with arrhythmias. A chest radiograph shows the anomalous course of the PAC along the left heart.

Entities:  

Mesh:

Year:  2000        PMID: 10662985     DOI: 10.1007/s001010050005

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  2 in total

1.  Persistent left superior vena cava as a cause for an unsuccessful ICD implant.

Authors:  S Fischer; T Höfs
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-04-18

2.  Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure.

Authors:  Musa Çakıcı; Adnan Doğan; Mustafa Çetin; Arif Süner; Mustafa Polat; Muhammed Oylumlu; Erdal Aktürk; Sabri Abus; Fatih Üçkardeş
Journal:  Anatol J Cardiol       Date:  2014-06-23       Impact factor: 1.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.